All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2006-002513-12 | A multi-center, randomized, double-blind, controlled Phase III study of the efficacy and safety of an oxygen-carrying colloid and plasma expander, Hemospan, compared with colloid (Voluven) for prevent... | 2008-06-11 | due-trials |
Not reported | 2006-002514-35 | A multi-center, randomized, double-blind, controlled Phase III study of the efficacy and safety of an oxygen-carrying colloid and plasma expander, Hemospan, compared with colloid (Voluven) for treatme... | 2008-04-27 | due-trials |
Completed, but no date Terminated | 2007-001538-15 | A randomized, single-blind, controlled Phase II pilot study of HemospanĀ® compared with colloid (VoluvenĀ®) to evaluate vascular resistance and blood flow in the forearm, and to assess local skin blood ... | bad-data | |
Not reported | 2009-013115-35 | A multi-center, randomized, double-blind, controlled dose-finding study to evaluate the safety and efficacy of MP4OX treatment plus standard of care in severely injured trauma patients with lactic aci... | 2010-07-16 | due-trials |
Listed as ongoing, but also has a completion date | 2010-023129-39 | A multi-center, randomized, double-blind, controlled study to evaluate the safety and efficacy of MP4OX treatment, in addition to standard treatment, in severely injured trauma patients with lactic ac... | 2012-10-29 | bad-data |
Not reported Terminated | 2013-001600-11 | A Phase 2 Multi-center, Randomized, Double-blind, Comparator-Controlled Dose Finding Study to Evaluate MP4CO for the Acute Treatment of Vaso-occlusive Crises in Subjects with Sickle Cell Disease | 2013-10-21 | due-trials |